Tang-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
202
Total Value
1807581363
Accession Number
0001214659-25-007882
Form Type
13F-HR
Manager Name
Tang-Capital-Management
Data Enrichment
98% identified
198 identified4 unidentified

Holdings

202 positions • $1.8B total value
Manager:
Search and click to pin securities to the top
Page 5 of 11
Janux Therapeutics, Inc.
Shares:150.0K
Value:$4.0M
% of Portfolio:0.2% ($4.0M/$1.8B)
CYTOKINETICS INC
Shares:100.0K
Value:$4.0M
% of Portfolio:0.2% ($4.0M/$1.8B)
COMPASS Pathways plc
Shares:1.4M
Value:$4.0M
% of Portfolio:0.2% ($4.0M/$1.8B)
TG THERAPEUTICS, INC.
Shares:100.0K
Value:$3.9M
% of Portfolio:0.2% ($3.9M/$1.8B)
GENMAB A/S
Shares:200.0K
Value:$3.9M
% of Portfolio:0.2% ($3.9M/$1.8B)
NOVAVAX INC
Shares:600.0K
Value:$3.8M
% of Portfolio:0.2% ($3.8M/$1.8B)
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Shares:40.0K
Value:$3.7M
% of Portfolio:0.2% ($3.7M/$1.8B)
Vera Therapeutics, Inc.
Shares:150.0K
Value:$3.6M
% of Portfolio:0.2% ($3.6M/$1.8B)
SOLENO THERAPEUTICS INC
Shares:50.0K
Value:$3.6M
% of Portfolio:0.2% ($3.6M/$1.8B)
Ventyx Biosciences, Inc.
Shares:3.1M
Value:$3.6M
% of Portfolio:0.2% ($3.6M/$1.8B)
Nuvalent, Inc.
Shares:50.0K
Value:$3.5M
% of Portfolio:0.2% ($3.5M/$1.8B)
Revolution Medicines, Inc.
Shares:100.0K
Value:$3.5M
% of Portfolio:0.2% ($3.5M/$1.8B)
Kezar Life Sciences, Inc.
Shares:720.0K
Value:$3.5M
% of Portfolio:0.2% ($3.5M/$1.8B)
Biohaven Ltd.
Shares:140.0K
Value:$3.4M
% of Portfolio:0.2% ($3.4M/$1.8B)
Stoke Therapeutics, Inc.
Shares:500.0K
Value:$3.3M
% of Portfolio:0.2% ($3.3M/$1.8B)
SpringWorks Therapeutics, Inc.
Shares:74.3K
Value:$3.3M
% of Portfolio:0.2% ($3.3M/$1.8B)
Vir Biotechnology, Inc.
Shares:500.0K
Value:$3.2M
% of Portfolio:0.2% ($3.2M/$1.8B)
Third Harmonic Bio, Inc.
Shares:929.7K
Value:$3.2M
% of Portfolio:0.2% ($3.2M/$1.8B)
PRECISION BIOSCIENCES INC
Shares:673.3K
Value:$3.2M
% of Portfolio:0.2% ($3.2M/$1.8B)
Black Diamond Therapeutics, Inc.
Shares:2.1M
Value:$3.2M
% of Portfolio:0.2% ($3.2M/$1.8B)